XILIS
Xilis is an oncology and precision health company that diagnoses cancer and finds the right treatment. The company uses “micro-organoids” to make thousands of 3D replicas of a patient’s tumor in about six days, which the company says can be used for testing for drug compatibility faster. It was founded in 2019 and is headquartered in Durham, North Carolina.
XILIS
Industry:
Biotechnology Health Care Health Diagnostics Life Science Pharmaceutical
Founded:
2019-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.xilis.com
Total Employee:
11+
Status:
Active
Total Funding:
92 M USD
Technology used in webpage:
SPF Amazon Google Apps For Business Amazon Virginia Region Amazon S3 CDN DMARC Atlassian Cloud Google DNS Google Domains Google Cloud DNS
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Flare Therapeutics
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Immunitas Therapeutics
Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.
Current Advisors List
Current Employees Featured
Founder
Investors List
FPV Ventures
FPV Ventures investment in Series A - Xilis
EQT
EQT investment in Series A - Xilis
Two Sigma Ventures
Two Sigma Ventures investment in Series A - Xilis
Mubadala Capital Ventures
Mubadala Capital Ventures investment in Series A - Xilis
GV
GV investment in Series A - Xilis
Alix Ventures
Alix Ventures investment in Series A - Xilis
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Xilis
Felicis Ventures
Felicis Ventures investment in Series A - Xilis
Duke Angel Network
Duke Angel Network investment in Series A - Xilis
Catalio Capital Management
Catalio Capital Management investment in Series A - Xilis
Official Site Inspections
http://www.xilis.com Semrush global rank: 584.13 K Semrush visits lastest month: 78.96 K
- Host name: ec2-3-225-38-252.compute-1.amazonaws.com
- IP address: 3.225.38.252
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Xilis"
Xilis - Crunchbase Company Profile & Funding
Xilis is a biotechnology company that develops technologies to guide precision therapy for cancer patients and accelerate drug discovery. The company's platform enables diagnostics, drug screening, and scalable patient-derived …See details»
About Us - Xilis
Cancer is the second leading cause of death in the U.S. and metastatic disease remains predominantly incurable. New cancer cases and healthcare costs continue to increase year-over-year. Precision medicine aims to select the …See details»
Our Founders & Our Story - Xilis
Xilis was founded in 2019 when the three founders -- an engineer, a physician and a biologist -- decided to develop and commercialize their technology to transform cancer care. As leaders in their respective fields and their unique …See details»
Xilis - Funding, Financials, Valuation & Investors - Crunchbase
Xilis is an oncology and precision health company that provides technologies to diagnoses cancer. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Xilis - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Xilis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... About. Xilis has 9 current employee profiles, including …See details»
Home - Xilis
Home - XilisSee details»
xilis - LinkedIn
Xilis’ proprietary #MicroOrganoSphere™ (MOS) technology represents a new standard in patient-derived micro-tumor production. From each patient, MOS retains unique patient tissue structure ...See details»
Xilis Company Profile 2024: Valuation, Funding & Investors
Xilis General Information Description. Developer of micro-organ sphere technology designed to guide precision therapy for cancer patients and accelerate drug discovery. The company's …See details»
Our Values - Xilis
At Xilis, we have an unwavering commitment to use our technology, skills, and time to provide patients with transformative new diagnostics and therapeutics. ... management of Xilis are …See details»
Xilis - EQT Group
Nov 22, 2024 xilis.com. Sector. Healthcare. Country. United States. Fund. LSP 6. Entry. 2021. Web. xilis.com. Latest news. 29 November 2024 EQT Exeter completes Spanish student housing portfolio sale to Azora; 26 November …See details»
This Startup Just Raised $70 Million To Grow Tiny Tumors That
Jul 8, 2021 Xiling Shen, CEO, Xilis, a company creates tumor organoids tumors in laboratory to test cancer drugs. Xilis. Around seven out of ten cancer patients don’t respond to drugs in the …See details»
Xilis and MD Anderson Announce Strategic Collaboration to …
Feb 15, 2023 To learn more about Xilis, visit Xilis.com. Founded in 2019 by Dr. Xiling Shen , Dr. David Hsu , and Dr. Hans Clevers , Xilis is based on decades of biomedical, oncology, and …See details»
Xilis - Updates, News, Events, Signals & Triggers - Crunchbase
Xilis is focused on developing technologies involving MicroOrganoSpheres (MOSs) for precision oncology applications. Their research includes methods for delivering components into MOSs …See details»
Leadership - Xilis
Prior to joining Xilis, Ryan lead strategy and business development at Herophilus, a neuroscience drug discovery startup that built a patient-derived brain organoid drug discovery platform and …See details»
Xilis Announces Formation of its Scientific Advisory Board
Dec 15, 2022 Xilis’ proprietary MicroOrganoSphere™ (MOS) Platform generates miniature patient tumors that capture the full microenvironment and heterogeneity and provides an …See details»
Xilis Raises $70 Million Series A Financing to Advance ... - Duke OTC
Nasdaq highlights Xilis on their tower in Times Square. — Xilis’ MicroOrganoSphereTM (MOS) technology generates thousands of miniature patient- derived tumors that capture the original …See details»
Investors - Xilis
Scroll to top ... ...See details»
Xilis’ Precision Oncology Platform Guides Treatment and Drug …
Jul 13, 2022 The Xilis founder and CEO says it all comes down to whether you have a good model to represent the patient’s tumor before putting the drug into the patient. “While …See details»
News & Publications - Xilis
Oct 15, 2021 Xilis in the News. Xilis Announces Formation of its Scientific Advisory Board. PR Newswire. December 15, 2022 Read More. Xilis Aims to Demonstrate Ability of Drug …See details»